Astellas Pharma Inc. - ALPMY

Sector: Funds · Industry: Investment Company
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$3.072M
QoQ value delta ($000)
+$29K (+0.95%)
Implied price effect (QoQ)
+0.48%
Shares
Total shares
228,580
QoQ shares delta
+1,077 (+0.47%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ALPMY)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
HANTZ FINANCIAL SERVICES, INC. 2,531 189,328 0.03%
RHUMBLINE ADVISERS 289 21,642 0.0%
GAMMA Investing LLC 195 13,511 0.01%
WELLINGTON-ALTUS USA INC. 31 2,017 0.02%
First Command Advisory Services, Inc. 17 1,278 0.0%
Salomon & Ludwin, LLC 9 734 0.0%
PNC FINANCIAL SERVICES GROUP, INC. 0 70 0.0%